Natural Autoantibodies in Chronic Pulmonary Diseases
Open Access
- 8 February 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (3) , 1138
Abstract
In autoantibody-mediated autoimmune diseases, pathogenic autoantibodies generated by a failure of central or peripheral tolerance, have different effects mediated by a variety of mechanisms. Interestingly, even non-autoimmune chronic diseases have a set of disease-specific natural autoantibodies that are maintained for a long time. Because most of these natural autoantibodies target intracellular proteins or long non-coding RNAs, they are speculated to be non-pathological and have some important as yet unrecognized physiological functions such as debris clearance. Recently, we revealed a set of disease-specific natural autoantibodies of chronic pulmonary diseases with unknown etiology by protein arrays that enable detection of specific autoantibodies against >8000 targets. Surprisingly, some of the targeted antigens of disease-specific autoantibodies were subsequently reported by other laboratories as strongly associated with the disease, suggesting that these antigens reflect the pathology of each disease. Furthermore, some of these autoantibodies that target extracellular antigens might modify the original course of each disease. Here, we review the disease-specific natural autoantibodies of chronic pulmonary diseases, including chronic fibrosing idiopathic interstitial pneumonias, sarcoidosis, and autoimmune pulmonary alveolar proteinosis, and discuss their utility and effects.Keywords
Funding Information
- Japan Society for the Promotion of Science (16K09537)
- Japan Agency for Medical Research and Development (JP19ek0109268)
This publication has 107 references indexed in Scilit:
- Characterization of pathogenic human monoclonal autoantibodies against GM-CSFProceedings of the National Academy of Sciences, 2013
- Natural IgG Autoantibodies Are Abundant and Ubiquitous in Human Sera, and Their Number Is Influenced By Age, Gender, and DiseasePLOS ONE, 2013
- Autoimmune disorder phenotypes in Hvcn1-deficient miceBiochemical Journal, 2013
- Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease modelsNature Genetics, 2012
- IL‐10 and IL‐10 receptor defects in humansAnnals of the New York Academy of Sciences, 2011
- Characterizing the RNA targets and position-dependent splicing regulation by TDP-43Nature Neuroscience, 2011
- The molecular basis of pulmonary alveolar proteinosisClinical Immunology, 2010
- HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen speciesNature Immunology, 2010
- Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosisBiochemical and Biophysical Research Communications, 2008
- Characteristics of a Large Cohort of Patients with Autoimmune Pulmonary Alveolar Proteinosis in JapanAmerican Journal of Respiratory and Critical Care Medicine, 2008